Categories
Cancer Clinical trials Medicine Politics

The USPSTF mammography guidelines and African American women: Do they even apply?

A while back I wrote about really rethinking how we screen for breast cancer using mammography. Basically, the USPSTF, an independent panel of physicians and health experts that makes nonbinding recommendations for the government on various health issues, reevaluated the evidence for routine screening mammography and concluded that for women at normal risk for breast […]

Categories
Cancer Medicine Politics Surgery

How not to protect your medical turf

When the USPSTF issued new guidelines for who should undergo screening mammography, at what ages, and how often, it set off a firestorm of negative reactions. Some of this is not surprising, given that the reevaluation of the evidence for screening mammography led the USPSTF to recommend against its routine use in women between the […]

Categories
Clinical trials Complementary and alternative medicine Medicine

Patient satisfaction versus quality of care, round two

About a month ago, I wrote about a study that looked at metrics of patient satisfaction and compared them to hard outcomes often used to evaluate quality of care, including frequency of emergency room usage, frequency of hospitalization, and overall mortality. Even though these days there appears to be an implicit assumption that increased patient […]

Categories
Cancer Clinical trials Medicine Politics

No, Virginia, cancer care in Europe doesn’t suck, contrary to what a recent paper implies

The U.S. is widely known to have the highest health care expenditures per capita in the world, and not just by a little, but by a lot. I’m not going to go into the reasons for this so much, other than to point out that how to rein in these costs has long been the […]

Categories
Cancer Clinical trials Medicine Surgery

Barriers to the adoption of new surgical procedures

Last week, I wrote about factors that lead to the premature adoption of surgical technologies and procedures, the “bandwagon” or “fad” effect among surgeons, if you will. By “premature,” I am referring to widespread adoption “in the trenches,” so to speak, of a procedure before good quality evidence from science and clinical trials show it […]